Viatris, Inc. (VTRS)
11.61
+0.02
(+0.17%)
USD |
NASDAQ |
Dec 12, 12:48
Viatris Cash from Investing (Quarterly): -98.90M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Amgen, Inc. | -414.00M |
| BioCryst Pharmaceuticals, Inc. | 13.57M |
| QuidelOrtho Corp. | -53.90M |
| Indivior PLC | -20.43M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 744.90M |
| Cash from Financing (Quarterly) | -228.10M |
| Free Cash Flow | 1.614B |
| Free Cash Flow Per Share (Quarterly) | 0.554 |
| Free Cash Flow to Equity (Quarterly) | 688.30M |
| Free Cash Flow to Firm (Quarterly) | 2.610B |
| Free Cash Flow Yield | 11.77% |